Endo (Keenova Therapeutics and Par Health)
(https://endo.com) 📸 Data Snapshot: May 30, 2026Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
The site suffers from a total absence of structured data, with schema_json being null across all crawled pages, which is a major authority gap for a supposed leading global therapeutics company. There are no named experts, founders, or scientists referenced in the text, preventing the verification of a digital footprint for company leadership. The technical implementation is sparse, with the ethics-and-compliance URL returning the same text as the homepage, suggesting a lack of technical maintenance during the corporate transition.
The site claims to be a leading global therapeutics company but fails to demonstrate this with any clinical trial data, pipeline specifics, or peer-reviewed study citations. The assertion of developing high-quality generics and sterile injectables is stated as a fact but is not backed by specific product lists or FDA 510(k) numbers. The gap between the marketing tone of breakthrough innovation and the actual content—which is mostly legal boilerplate—is substantial.
Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
🛡️ Trust Signals — external proof links that back the declared identity
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 0 |
| /privacy-legal/ | 28 | 0 |
| /responsibility/ethics-and-compliance/ | 0 | 0 |
This page presents a snapshot of public data from Endo (Keenova Therapeutics and Par Health), captured on May 30, 2026, to show how machine logic reads Identity & Authority signals into an AI reputation evaluation.
Purpose: This data is presented under “Fair Use” for the purpose of independent signal analysis, allowing readers to see the raw signals behind the reputation score.
Notice to Endo (Keenova Therapeutics and Par Health): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results are intended as professional feedback to help improve any website’s machine-readability and authority signals. The evaluation is free, and any company can request a fresh audit at any time.
Any company can use the insights for free and improve its voice. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://endo.com to view the most current version of its content and see directly what this company is about and what it offers.